Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.71 USD | -4.70% | -1.39% | -13.59% |
05-13 | Tocagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.59% | 25.84M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.47% | 21.93B | |
-12.15% | 22.34B | |
-5.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences : Chardan Adjusts Forte Biosciences' Price Target to $115 From $110, Keeps at Buy